Inogen, Inc.
Market Cap
$168.84M
P/E Ratio
-7.21
EPS
$-0.86
Dividend Yield
0.00%
52-Week Range
$5.34 — $9.13
Volume
219.88K
Avg Volume
266.63K
Beta
1.78
P/E (TTM)
-7.21
Forward P/E
—
PEG Ratio
-0.51
P/S (TTM)
0.49
P/B (TTM)
0.89
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-0.12%
ROA (TTM)
-0.08%
ROIC
—
Gross Margin
0.48%
Operating Margin
-0.09%
Net Margin
—
Debt/Equity
0.09
Current Ratio
3.12
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
-3.89%
EPS Growth (5Y)
-2.59%
Sales Growth (3Y)
-0.02%
Sales Growth (5Y)
-0.01%
EPS Est (This Year)
$-0.68
EPS Est (Next Year)
$-0.62
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$4.40
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
27.15M
Float
24.06M
Free Float %
88.62%
Sector
Healthcare
Industry
Medical - Devices
Country
US
Exchange
NASDAQ
IPO Date
2014-02-14
Employees
766
CEO
Kevin R. Smith
Index Membership
—
Website
https://www.inogen.com
Inogen, Inc. (INGN) is a healthcare company in the medical - devices industry listed on the NASDAQ. With a market capitalization of $168.84M, a P/E ratio of -7.21, INGN is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare INGN against other stocks using dozens of fundamental and technical filters.
Inogen, Inc. (INGN) has a trailing twelve-month (TTM) P/E ratio of -7.21. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Inogen, Inc. (INGN) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Inogen, Inc. (INGN) has a market capitalization of $168.84 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.